COVID-19相关脑出血的影像特征与超早期血肿增长
多中心回顾性病例对照研究比较33例COVID-19合并脑出血患者与321例无COVID-19的脑出血对照,发现COVID-19组多灶性出血和NCCT征象更常见,超早期血肿增长率更高(中位6.2 mL/h vs 3.1 mL/h,p=0.027),校正混杂因素后仍显著。
要点
- COVID-19合并脑出血患者多灶性出血及NCCT征象(血肿内低密度、密度不均、混合征、液平)更常见。
- COVID-19组超早期血肿增长率中位6.2 mL/h,高于对照组的3.1 mL/h(p=0.027)。
- 该关联校正血压及抗血小板/抗凝治疗后仍显著,排除抗凝治疗患者后仍一致。
核心结论
- COVID-19相关脑出血具有独特的NCCT影像特征和更高的出血速度,该关联并非由抗血栓治疗介导,值得进一步研究其潜在生物学机制。
研究设计与样本
- 多中心、回顾性、病例对照分析,纳入33例COVID-19合并脑出血患者(COV19+)与321例无COVID-19的脑出血对照(COV19-),分析NCCT征象、出血部位及ABC/2法血肿体积,以NCCT基线血肿体积/发病至影像时间为超早期血肿增长率(uHG),采用多变量线性回归探索预测因素。
关键影像表现/征象
- COV19+组多灶性出血和NCCT征象(血肿内低密度、密度不均、混合征、不规则液平)较COV19-组显著更常见。
- COV19+组超早期血肿增长率中位6.2 mL/h,COV19-组中位3.1 mL/h(p=0.027)。
诊断标准与关键数值
- 超早期血肿增长率(uHG)定义为NCCT基线血肿体积除以发病至影像时间。
- 血肿体积采用ABC/2法测量,NCCT征象包括血肿内低密度、密度不均、混合征和不规则液平。
- COV19+组uHG中位6.2 mL/h vs COV19-组3.1 mL/h(p=0.027),校正收缩压、抗血小板及抗凝治疗后线性回归B(SE)=0.31(0.11),p=0.005。
- 排除抗凝治疗患者后线性回归B(SE)=0.29(0.13),p=0.026。
临床应用与阅片要点
- 对COVID-19合并脑出血患者阅片时,应关注多灶性出血及血肿内低密度、密度不均、混合征、不规则液平等NCCT征象。
- 报告时可结合发病至影像时间评估超早期血肿增长率,COVID-19组中位uHG为6.2 mL/h,高于无COVID-19组的3.1 mL/h。
局限性
- 原文结论指出该关联值得进一步研究以明确其潜在生物学机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Intracerebral hemorrhage (ICH) is an uncommon but deadly event in patients with COVID-19 and its imaging features remain poorly characterized. We aimed to describe the clinical and imaging features of COVID-19-associated ICH.
METHODS: Multicenter, retrospective, case-control analysis comparing ICH in COVID-19 patients (COV19 +) versus controls without COVID-19 (COV19 -). Clinical presentation, laboratory markers, and severity of COVID-19 disease were recorded. Non-contrast computed tomography (NCCT) markers (intrahematoma hypodensity, heterogeneous density, blend sign, irregular shape fluid level), ICH location, and hematoma volume (ABC/2 method) were analyzed. The outcome of interest was ultraearly hematoma growth (uHG) (defined as NCCT baseline ICH volume/onset-to-imaging time), whose predictors were explored with multivariable linear regression.
RESULTS: A total of 33 COV19 + patients and 321 COV19 - controls with ICH were included. Demographic characteristics and vascular risk factors were similar in the two groups. Multifocal ICH and NCCT markers were significantly more common in the COV19 + population. uHG was significantly higher among COV19 + patients (median 6.2 mL/h vs 3.1 mL/h, p = 0.027), and this finding remained significant after adjustment for confounding factors (systolic blood pressure, antiplatelet and anticoagulant therapy), in linear regression (B(SE) = 0.31 (0.11), p = 0.005). This association remained consistent also after the exclusion of patients under anticoagulant treatment (B(SE) = 0.29 (0.13), p = 0.026).
CONCLUSIONS: ICH in COV19 + patients has distinct NCCT imaging features and a higher speed of bleeding. This association is not mediated by antithrombotic therapy and deserves further research to characterize the underlying biological mechanisms.
引用
- Morotti, Pilotto, Mazzoleni, et al. Imaging features and ultraearly hematoma growth in intracerebral hemorrhage associated with COVID-19. Neuroradiology. 2022. PMID: 35034151. doi:10.1007/s00234-021-02861-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。